Vimarsana
Biggest News Aggregation in the World

Page 14 - Immunic Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Inc Today - Breaking & Trending Today

Immunic to Participate in Scientific and Investor Conferences in July - Vimarsana News

Immunic to Participate in Scientific and Investor Conferences in July

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

EQS-News: Immunic to Participate in Scientific and Investor Conferences in July - Vimarsana News

EQS-News: Immunic to Participate in Scientific and Investor Conferences in July

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Scientific and Investor Conferences in July 29.06.2023 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate in Scientific and Investor Conferences in July NEW YORK,...

These 2 'Strong Buy' Penny Stocks Could Soar to $25 (Or Higher), Says Piper Sandler - Vimarsana News

These 2 'Strong Buy' Penny Stocks Could Soar to $25 (Or Higher), Says Piper Sandler

Whether you love them or hate them, penny stocks are contentious. These tickers, which trade for less than $5 per share, have earned a reputation on Wall Street for their divisive nature, leaving investors struggling to find common ground on the matter. The appeal is clear. For the same price as one share of a more well-known company, investors can snap up hundreds of shares of a penny stock. What’s more, the fact that even minor share price appreciation can translate to irresistible percentage

Source: yahoo.com
Immunic, Inc. (NASDAQ:IMUX) Short Interest Down 28.3% in May - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Short Interest Down 28.3% in May

Immunic, Inc. (NASDAQ:IMUX – Get Rating) was the recipient of a large drop in short interest in May. As of May 31st, there was short interest totalling 2,330,000 shares, a drop of 28.3% from the May 15th total of 3,250,000 shares. Based on an average daily volume of 1,150,000 shares, the days-to-cover ratio is presently […]

Immunic Inc has a blockbuster clinical pipeline to treat multiple sclerosis and gastrointestinal diseases - Vimarsana News

Immunic Inc has a blockbuster clinical pipeline to treat multiple sclerosis and gastrointestinal diseases

New York-based biotechnology company Immunic Inc (NASDAQ:IMUX) has one or more potential blockbusters in its clinical pipeline. The firm’s promising lead...